Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-022441-21Phase 4Completed
Phase 4, open-label, single-arm trial of pelargonium sidoides extract in nasopharyngitis, sponsored by Schwabe Group. Primary endpoint: Adverse events surveillance. Started Nov 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-022441-21.